A randomized controlled trial comparing split and subunit influenza vaccines in adults in columbia

Medicina

Volumn 63, Issue 3, 2003, Pages 197-204

  Morales, Alvaro ^a   Salazar, Javier Arias ^a   Salazar, Yolanda ^a   Garcia, Albert ^b   Arnoux, Sabine ^b   Arancibia, Andrea ^b   Deroche, Christele ^b   Rey, Elena ^b  

^a Siplas LTDA ^*

^b SANOFI PASTEUR   (France)

Author keywords

Adults; Influenza vaccine; Split; Sub unit

Indexed keywords

AGRIPPAL S1; DIPLOID CELL VACCINE; IMOVAX GRIPE; INFLUENZA VACCINE; SUBUNIT VACCINE;

ADULT; ANTIBODY TITER; ARTHRALGIA; ARTICLE; ASTHENIA; BLOOD SAMPLING; BRONCHOSPASM; CLINICAL TRIAL; COLOMBIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; ECCHYMOSIS; EDEMA; ERYTHEMA; EXPERIMENTAL DESIGN; FEMALE; FEVER; GROUPS BY AGE; HEADACHE; HUMAN; HYPERHIDROSIS; HYPOTENSION; IMMUNOREACTIVITY; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; PAIN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SHIVERING; SINGLE DRUG DOSE; SKIN INDURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; FEMALE; HUMANS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; VACCINATION; VACCINES, SUBUNIT;

EID: 0038637018     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. LaForce FM, Nichol KL, Cox NJ. Influenza: virology, epidemiology, disease and prevention. Am J Prev Med 1994;10(Suppl): 31-44.
2. Palache AM. Influenza subunit vaccine - ten years experience. Europ J Clin Res 1992; 3: 117-38.
3. Nichol KL, Lind A, Margokis KL, et al. The effectiveness of vaccination against influenza in healthy working adults. NEJM 1995; 333: 889-93.
4. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunisation practices (ACIP). MMWR 2000; 49 (No. RR30): 1-38.
5. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999; 17: S3-S10.
6. Savy V. Regional perspectives on influenza surveillance in South America. Vaccine 2002; 20: S47-S49.
7. Pan American Health Organization (PAHO). Report: Third meeting of the surveillance networks for emerging infectious diseases in the Amazon and southern cone regions. (PAHO/HCP/HCT/178/01) http://www.paho.org/English/HCP/HCT/EER/atianta_july2000,pdf.
8. Ambrosch F, Fedson DS. Influenza vaccination in 29 countries. (An update to 1997). Pharmocoeconomics 1999 16 (Suppl 1): 47-54.
9. Kilbourne ED, Arden NH. Inactivated influenza vaccines. In Vaccines, 3rd edition, Plotkin SA & Orenstein WA, Philaddelphia, WB Saunders Company, 1999, pp. 531-552.
10. Lina B, Fletcher MA, Valette M, Saliou P, Aymard M. A Triton X-100-split virion influenza vaccine is safe and fulfills the Committee for Proprietary Medicinal Products (CPMP) recommendations for the European Community for immunogenicity, in children, adults and the elderly. Biologicals 2000; 28: 95-103.
11. World Medical Association. Declaration of Helsinki (as revised). http://www.wma.net/e/policy/17-c_e.html.
12. National Advisory Committee on Immunization Practices (NACI): Statement on influenza vaccination for the 1999-2000 season. Can Com Dis Rep 1999; 25: 1-15.
13. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonization of requirements for influenza vaccine. (CPMP/BWP/214/96).
14. Glathe H, Bigl S, Grosche A. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people. Vaccine 1993; 11: 702-5.
15. Levine M, Beattie BL, McLean DM, Corman D. Characterization of the immune response to trivalent influenza vaccine in elderly men. J Am Geriatr Soc 1987; 35: 609-15.
16. Honkanen PO, Keistinen T, Kivela S-L. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med 1996; 156: 205-8.
17. Beyer WE, Palache AM, Baljet M, Masurel N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 1989; 7: 385-94.
18. Jianping H, Xin F, Changshun L, et al. Assessment of effectiveness of Vaxigrip. Vaccine 1999; 17: S57-S58.
19. Iorio AM, Rivosecchi P, Zei T, Neri M, Merletti L. Immune response to trivalent inactivated influenza vaccine in young, middle-aged and elderly subjects. Vaccine 1989; 7: 341-4.
20. Jennings R, Smith TL, Spencer RC, et al. Inactivated influenza virus vaccines in man: a comparative study of subunit and split vaccines using two methods for assessment of antibody responses. Vaccine 1984; 2: 75-80.
21. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski, RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518-27.
22. Beyer WEP, Palache AM, Osterhaus ADME. Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines: a review and meta-analysis of the literature. Clin Drug Invest 1998; 15: 1-12.
23. Gross PA, Quinnan GV, Gaarlan PF, Denning CR, Lazicki M, Bernius M. Influenza vaccines in children: comparison of new cetrimonium bromide and standard ether-treated vaccines. Am J Dis Child 1983; 137: 26-8.
24. Spila-Alegiani S, Salmaso S, Rota MC, Tozzi AE, Raschetti R, the Italian SVEVA group. Reactogenicity in the elderly of nine commercial influenza vaccines: results from the Italian SVEVA study. Vaccine 1999; 17: 1898-904.
25. Govaert ME, Dinant GJ, Aretz K, Masurel N, Sprenger MJW, Knottnerus JA. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ 1993: 307: 988-90.
26. Margolis, KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly: a randomized placebo controlled trial. JAMA 1990; 254: 1139-41.
27. Nichol KL, Margolis KL, Lind A, et al. Side effects associated with influenza vaccination in healthy working adults: a randomised placebo controlled trial. Arch Intern Med 1996; 156: 1546-50.
28. Wood SC, Nguyen NH, Schmidt C. Economic evaluations of influenza vaccination in healthy working-age adults: a critical review of the literature. Pharmacoeconomics 2000; 18: 173-83.
29. Wood SC, Nguyen VH, Schmidt C. Economic evaluations of influenza vaccination in the elderly and their impact on public health policy. Dis Management Health Outcomes 2000; 8: 273-85.